Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyung-Sang Yu

Showing results (31-40 of 349) with videos related to

Pageof 35
Sort By:
Drug Design, Development and Therapy|February 23, 2023
Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated RabeprazoleSungyeun Bae, Jihoon Kwon, Mi-Hye Lee, et al.
Drug Design, Development and Therapy|February 25, 2021
Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover StudyEunsol Yang, Hyounggyoon Yoo, In-Jin Jang, et al.
Journal of Medical Ethics|June 29, 2011
Discrepancy between participants' understanding and desire to know in informed consent: are they informed about what they really want to know?Jiwon Koh, Eurah Goh, Kyung-Sang Yu, et al.
Drug Design, Development and Therapy|September 11, 2015
Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjectsSeonghae Yoon, Donghoon Shin, Howard Lee, et al.
Drug Design, Development and Therapy|December 2, 2020
Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male SubjectsHyounggyoon Yoo, Yun Kim, In-Jin Jang, et al.
Neurology and Therapy|August 10, 2024
Population Pharmacokinetic Modeling and Simulation for Dose Optimization of GB-5001, a Long-Acting Intramuscular Injection of Donepezil, in Healthy ParticipantsJuyoung Khwarg, Heeyong Lee, Kyung-Sang Yu, et al.
Translational and Clinical Pharmacology|January 11, 2021
Electronic medical records-based comparison of glycemic control efficacy between sulfonylureas and dipeptidyl peptidase-4 inhibitors added on to metformin monotherapy in patients with type 2 diabetesSuhrin Lee, SeungHwan Lee, In-Jin Jang, et al.
Clinical Pharmacology in Drug Development|July 25, 2023
Pharmacokinetic Comparison Between a Fixed-Dose Combination of Empagliflozin L-Proline/Metformin and Empagliflozin/Metformin in Healthy Korean SubjectsHyunJoon Lee, Jae-Yong Chung, Kyung-Sang Yu, et al.
Clinical and Translational Science|May 12, 2025
Safety, Tolerability, and Pharmacokinetics of Single and Multiple Topical Applications of Sodium Taurodeoxycholate, a Treatment for Atopic DermatitisHeejae Won, Inseung Jeon, Joo-Youn Cho, et al.
Clinical Drug Investigation|February 5, 2017
Changes in Cardiac Function After a Single Intravenous Administration of CKD-712 in Healthy Male VolunteersSang-In Park, JaeWoo Kim, Kyung-Sang Yu, et al.
Pageof 35

Showing results (31-40 of 349) with videos related to

Sort By:
Pageof 35
Drug Design, Development and Therapy|February 23, 2023
Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated RabeprazoleSungyeun Bae, Jihoon Kwon, Mi-Hye Lee, et al.
Drug Design, Development and Therapy|February 25, 2021
Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover StudyEunsol Yang, Hyounggyoon Yoo, In-Jin Jang, et al.
Journal of Medical Ethics|June 29, 2011
Discrepancy between participants' understanding and desire to know in informed consent: are they informed about what they really want to know?Jiwon Koh, Eurah Goh, Kyung-Sang Yu, et al.
Drug Design, Development and Therapy|September 11, 2015
Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjectsSeonghae Yoon, Donghoon Shin, Howard Lee, et al.
Drug Design, Development and Therapy|December 2, 2020
Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male SubjectsHyounggyoon Yoo, Yun Kim, In-Jin Jang, et al.
Neurology and Therapy|August 10, 2024
Population Pharmacokinetic Modeling and Simulation for Dose Optimization of GB-5001, a Long-Acting Intramuscular Injection of Donepezil, in Healthy ParticipantsJuyoung Khwarg, Heeyong Lee, Kyung-Sang Yu, et al.
Translational and Clinical Pharmacology|January 11, 2021
Electronic medical records-based comparison of glycemic control efficacy between sulfonylureas and dipeptidyl peptidase-4 inhibitors added on to metformin monotherapy in patients with type 2 diabetesSuhrin Lee, SeungHwan Lee, In-Jin Jang, et al.
Clinical Pharmacology in Drug Development|July 25, 2023
Pharmacokinetic Comparison Between a Fixed-Dose Combination of Empagliflozin L-Proline/Metformin and Empagliflozin/Metformin in Healthy Korean SubjectsHyunJoon Lee, Jae-Yong Chung, Kyung-Sang Yu, et al.
Clinical and Translational Science|May 12, 2025
Safety, Tolerability, and Pharmacokinetics of Single and Multiple Topical Applications of Sodium Taurodeoxycholate, a Treatment for Atopic DermatitisHeejae Won, Inseung Jeon, Joo-Youn Cho, et al.
Clinical Drug Investigation|February 5, 2017
Changes in Cardiac Function After a Single Intravenous Administration of CKD-712 in Healthy Male VolunteersSang-In Park, JaeWoo Kim, Kyung-Sang Yu, et al.
Pageof 35